According to a market report by Lucintel, the future of the digital therapeutic device market looks promising with opportunities in preventive and treatment/care such as obesity, diabetes, cardiovascular disease, respiratory disease, and musculoskeletal diseases. The digital therapeutic device market is expected to grow with a CAGR of 27% from 2019 to 2024. The major growth drivers for this market are increasing incidence of preventable chronic diseases, rising focus on preventive healthcare, technological advancements, significant increase in venture capital investments, and rising healthcare cost.
In this market, pain management devices, respiratory therapy devices, rehabilitation devices, and insulin pumps are the major devices used for digital and online health technologies. Insulin pump is the largest segment of the digital therapeutic device market.
To download report brochure, please go to https://www.lucintel.com/digital-therapeutic-device-market.aspx and click "report brochure" tab from the menu.
Preventive (prediabetes, obesity, smoking cessation), and treatment/care (diabetes, cardiovascular diseases, and central nervous system disease, respiratory diseases, musculoskeletal diseases, and medication adherence) are the major applications of the digital therapeutic device market.
North America will remain the largest market over the forecast period due to rise in elderly population requiring better healthcare facilities, presence of large number of digital therapy providers in the region, high rate of adoption of advanced medical devices, and rise in the demand for patient-centric healthcare procedures.
Proteus Digital Health, Omada Health, Welldoc, Livongo Health, Noom, Ginger.Io, Propeller Health, 2morrow, Canary Health, and Mango Health are among the major manufacturers of digital therapeutic device.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the digital therapeutic device market by application, end use, device, and region. Lucintel has prepared a comprehensive research report titled “Digital Therapeutic Device Market 2019-2024: Trends, Forecast, and Opportunity Analysis”. This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the digital therapeutic device market by application, end use, device, and region as follows:
By Application [$M shipment analysis for 2013 – 2024]:
Preventive
Prediabetes
Obesity
Smoking Cessation
Others
Treatment/Care
Diabetes
Cardiovascular Diseases
Central Nervous System Diseases
Respiratory Diseases
Others
By End Use [$M shipment analysis for 2013 – 2024]:
Patients
Caregivers
Providers
Payers
Employers
Pharmaceutical Companies
Others
By Device Type [$M shipment analysis for 2013 – 2024]:
Respiratory Therapy Devices
Pain Management Devices
Insulin Pumps
Rehabilitation Device
Others
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
Asia Pacific
Rest of the World
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/digital-therapeutic-device-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.